Access cutting-edge liver fibrosis treatment through this clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.
Access liver fibrosis specialists in Dallas at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver fibrosis treatment provided free
Prospective randomized, multi-center, double blind placebo-controlled trial to assess the chemopreventive impact of atorvastatin (20 mg oral) vs placebo in up to 60 adults with advanced fibrosis at high risk of developing HCC.
Sponsor: Raymond Chung
Check if you qualify for this liver fibrosis clinical trial in Dallas, TX
If you're searching for liver fibrosis treatment options in Dallas, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Dallas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.